Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for Autolus Therapeutics (AUTL) over the last 8 years, with Q3 2025 value amounting to $501000.0.

  • Autolus Therapeutics' Gains from Investment Securities fell 2362.8% to $501000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 4521.24%. This contributed to the annual value of $2.4 million for FY2024, which is 9418.93% down from last year.
  • As of Q3 2025, Autolus Therapeutics' Gains from Investment Securities stood at $501000.0, which was down 2362.8% from $967000.0 recorded in Q2 2025.
  • Autolus Therapeutics' 5-year Gains from Investment Securities high stood at $28.5 million for Q3 2021, and its period low was -$29.2 million during Q4 2021.
  • Moreover, its 5-year median value for Gains from Investment Securities was $859000.0 (2024), whereas its average is $3.9 million.
  • Per our database at Business Quant, Autolus Therapeutics' Gains from Investment Securities plummeted by 20793.55% in 2021 and then skyrocketed by 1447543.86% in 2023.
  • Over the past 5 years, Autolus Therapeutics' Gains from Investment Securities (Quarter) stood at -$29.2 million in 2021, then soared by 133.33% to $9.7 million in 2022, then plummeted by 100.65% to -$63000.0 in 2023, then soared by 1292.06% to $751000.0 in 2024, then plummeted by 33.29% to $501000.0 in 2025.
  • Its Gains from Investment Securities stands at $501000.0 for Q3 2025, versus $967000.0 for Q2 2025 and $71000.0 for Q1 2025.